Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Conundrums with FlowPRA beads.

Howard M Gebel1, Shealynn B Harris, G Zibari

  • 1Department of Pathology, Emory University Hospital, Atlanta, GA 30322, USA.

Clinical Transplantation
|October 10, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Apparent maternal exclusion explained by a MICA deletion.

Human immunology·2025
Same author

Virtual crossmatching: Principles, practices, and the path forward-An American Society for Histocompatibility and Immunogenetics/College of American Pathologists collaborative.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2025
Same author

Antigen quantity is responsible for the discrepancy between phenotype and single antigen beads for the detection of human leukocyte antigen DQ antibody: Potential clinical implications.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2025
Same author

The questions not addressed: Who should be performing the virtual crossmatch, how should it be classified, and how to obtain reimbursement?

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2025
Same author

From hero to zero: A single center retrospective review of the utility of routine physical crossmatching.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2025
Same author

Mitigating the Prozone-Like Effect in HLA Antibody Testing: A Case Report of Therapeutic Plasma Exchange for Antibody-Mediated Rejection Post-Heart Transplantation.

Journal of clinical apheresis·2024
Same journal

Incidence and Impact of RAS-Like Opacities During Preserved Lung Function After Lung Transplantation.

Clinical transplantation·2026
Same journal

Sequential Donation: Evaluating Safety and Quality of Life of Living Donors.

Clinical transplantation·2026
Same journal

Pretransplant Malnutrition Risk Components are Associated With Adverse Outcomes After Simultaneous Pancreas and Kidney and Solitary Pancreas Transplantation.

Clinical transplantation·2026
Same journal

Feasibility, Safety and Outcomes of Early Mobilization in the ICU Following Lung Transplantation: A Scoping Review.

Clinical transplantation·2026
Same journal

Randomized Controlled Trial of a Digital Intervention (KidneyTIME) to Promote Live Donor Kidney Transplantation.

Clinical transplantation·2026
Same journal

Arterio-Enteric Fistula Arising From a Residual Transplant Renal Artery Stump 20 Years After Transplant Nephrectomy.

Clinical transplantation·2026
See all related articles

The flow cytometric cross-match (FCXM) can yield unexpected results, with some positive FCXM tests not correlating with HLA antibodies detected by FlowPRA. This challenges the interpretation of cross-match tests in kidney transplantation.

Area of Science:

  • Immunology
  • Transplantation immunology
  • Histocompatibility testing

Background:

  • The pre-transplant cross-match is crucial for preventing hyperacute allograft rejection in renal transplantation.
  • The flow cytometric cross-match (FCXM) offers increased sensitivity for detecting antibodies but its clinical relevance is debated.
  • Solid phase immunoassays like FlowPRA aim to identify specific HLA antibodies, aiding cross-match interpretation.

Purpose of the Study:

  • To investigate unexpected discrepancies between FlowPRA and FCXM results.
  • To determine the clinical relevance of antibodies identified by FlowPRA and FCXM.
  • To re-evaluate the interpretation of cross-match results in light of new immunoassay technologies.

Main Methods:

  • Analysis of patient sera using FlowPRA (solid phase immunoassay) and FCXM (flow cytometric cross-match).

Related Experiment Videos

  • Investigation of unexpected serum patterns, including FlowPRA positive/FCXM negative and FlowPRA negative/FCXM positive.
  • Utilized sequence analysis and cell-based panel reactive antibody (PRA) approaches for further characterization.

    • Main Results:

    • Observed Pattern 1: FlowPRA positive for HLA Class I antibodies, but FCXM negative.
    • Observed Pattern 2: FlowPRA negative, yet FCXM positive for T and B cell antibodies.
    • Identified anti-HLA Class I activity in FlowPRA negative/FCXM positive sera via cell-based PRA.

    Conclusions:

    • The interpretation of FCXM results is complex and not always straightforward.
    • Unexpected discrepancies between FlowPRA and FCXM suggest the presence of clinically relevant antibodies.
    • Further research is needed to fully understand the implications of these findings for transplant outcomes.